...
首页> 外文期刊>Hormone and Metabolic Research >Effect of membrane solubilization on the inhibition of rat and hamster liver microsomal type i 11β-hydroxysteroid dehydrogenase by bile acids
【24h】

Effect of membrane solubilization on the inhibition of rat and hamster liver microsomal type i 11β-hydroxysteroid dehydrogenase by bile acids

机译:膜溶解对胆汁酸抑制大鼠和仓鼠肝i型11β-羟类固醇脱氢酶的影响

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to investigate the differences between rats and hamsters, Two of the most widely used experimental animals, with respect to the effects of microsomal membrane solubilization on the inhibition of liver 11β-hydroxysteroid dehydrogenase (11β-HSDI) enzyme by bile acids. Liver microsome fractions were prepared, and the 11β-HSDI enzymatic activity was measured using cortisone as a substrate. The substrate and various concentrations of bile acids were added to the assay mixtures. After incubation, the products were extracted and analyzed using high-performance liquid chromatography. To investigate the effect of detergent on the inhibitory effects of bile acids, we conducted inhibition tests using Triton X-100-solubilized animal liver microsomes. When solubilized microsomes were used, all bile acids inhibited 11β-HSDI from rats and hamsters to various degrees. 7α-Hydroxycholanoic acids (cholic acid and chenodeoxycholic acid) in particular had strong inhibitory activities. In hamsters, 7β- hydroxycholanoic acid (ursodeoxycholic acid) was the strongest inhibitor among the bile acids tested, although its effect was not very strong. When nonsolubilized microsomes were used, deoxycholic acid did not inhibit but rather enhanced the enzymatic activity in both animals. Microsomal content of cholesterol and phospholipids are significantly different between rats and hamsters. Species differences in bile acid inhibition of nonsolubilized microsomes might be reflected not only by structural difference of bile acids, which affect membrane solubilization and enzyme activity directly, but also species difference in microsomal membrane lipid content.
机译:这项研究的目的是为了研究大鼠和仓鼠之间的差异,这是两种使用最广泛的实验动物,在微粒体膜增溶对胆汁抑制肝脏11β-羟类固醇脱氢酶(11β-HSDI)酶的影响方面酸。制备肝微粒体级分,并以可的松为底物测量11β-HSDI的酶活性。将底物和各种浓度的胆汁酸加入测定混合物中。温育后,提取产物并使用高效液相色谱法分析。为了研究去污剂对胆汁酸抑制作用的影响,我们使用Triton X-100增溶的动物肝微粒体进行了抑制试验。当使用增溶的微粒体时,所有胆汁酸都会不同程度地抑制大鼠和仓鼠的11β-HSDI。特别是7α-羟基胆酸(胆酸和鹅去氧胆酸)具有强的抑制活性。在仓鼠中,7β-羟基胆酸(熊去氧胆酸)是胆汁酸中最强的抑制剂,尽管其作用不是很强。当使用非增溶的微粒体时,脱氧胆酸在两只动物中都没有抑制而是增强了酶的活性。在大鼠和仓鼠之间,胆固醇和磷脂的微粒体含量显着不同。胆汁酸对非增溶微粒体的抑制作用的物种差异可能不仅反映在胆汁酸的结构差异上,这直接影响膜的溶解性和酶活性,而且还反映了微粒体膜脂质含量的物种差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号